全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Clinical Profile and Outcomes of Acute and Chronic Type 5 Cardiorenal Syndrome

DOI: 10.4236/oalib.1112017, PP. 1-10

Subject Areas: Nephrology

Keywords: Type 5 Cardiorenal Syndrome, Sepsis, Systemic Disease, Acute Kidney Injury, Diabetes

Full-Text   Cite this paper   Add to My Lib

Abstract

Introduction: Type 5 cardiorenal syndrome (CRS) is characterized by the combination of renal failure and heart failure secondary to an acute or chronic systemic disease. The most common situation of acute systemic involvement responsible for type 5 CRS is sepsis. The objective of our study is to determine the epidemiological, clinical, and therapeutic profile of patients with acute and chronic type 5 CRS and to identify the prognostic factors associated with type 5 CRS. Materials and Methods: This is a descriptive and analytical study conducted between the nephrology and cardiology departments of the Ibn Sina University Hospital in Rabat. Over a period of one year, we identified 120 patients with CRS. We studied and analyzed patients with type 5 CRS (46%). Two groups of patients with type 5 CRS were defined and compared to analyze the epidemiological, clinical, and therapeutic profile of each group. Group 1 included patients with acute type 5 CRS, and Group 2 included patients with chronic type 5 CRS. We also investigated the risk factors for mortality associated with type 5 CRS. Results: Among the 120 patients with CRS, those with type 5 CRS represent 46%. Chronic type 5 CRS is significantly associated with diabetes, hypertension, and chronic kidney disease (CKD). AL amyloidosis was found in two of our patients with chronic type 5 CRS. Acute type 5 CRS was found in 20% of our patients, with severe sepsis being the predominant etiology in 72% of cases, followed by systemic lupus erythematosus in 28% of cases. The use of renal replacement therapy (RRT) was indicated in 45.5% of patients in Group 1, while mortality occurred in 36.4% of these patients. In univariate and multivariate analysis, we found that the risk factors for mortality associated with type 5 CRS are prolonged stays in the cardiac intensive care unit (CICU), the use of RRT, and acute type 5 CRS (p = 0.015, p = 0.031, p = 0.04). Conclusion: In our study, the prevalence of type 5 CRS is 46%. The etiology of acute type 5 CRS is dominated by sepsis, whereas chronic type 5 CRS is dominated by diabetes and hypertension. The risk factors for mortality associated with type 5 CRS are primarily; acute type 5 CRS, prolonged stays in CICU, and the use of RRT.

Cite this paper

Galiou, M. E. , Hilali, S. E. , Ouzeddoun, N. , Bouattar, T. , Doghmi, N. , Lahlou, L. and Benamar, L. (2024). Clinical Profile and Outcomes of Acute and Chronic Type 5 Cardiorenal Syndrome. Open Access Library Journal, 11, e2017. doi: http://dx.doi.org/10.4236/oalib.1112017.

References

[1]  Michel, T., Prudhomme, M. and Gayat, é. (2018) Le syndrome cardio-rénal. Anesthésie & Réanimation, 4, 386-396. https://doi.org/10.1016/j.anrea.2018.07.005
[2]  Jafri, S.M., Lavine, S., Field, B.E., Ahorozian, M.T. and Carlson, R.W. (1990) Left Ventricular Diastolic Function in Sepsis. Critical Care Medicine, 18, 709-714. https://doi.org/10.1097/00003246-199007000-00005
[3]  Ostermann, M. and Joannidis, M. (2016) Acute Kidney In-jury 2016: Diagnosis and Diagnostic Workup. Critical Care, 20, Article No. 299. https://doi.org/10.1186/s13054-016-1478-z
[4]  Livio, F., Biollaz, J. and Burnier, M. (2008) Estimation of Renal Function by the MDRD Equation: Interest and Limits for Drug Dose Adjustment. Revue Médicale Suisse, 4, 2596-2600. https://doi.org/10.53738/REVMED.2008.4.181.2596
[5]  McDonagh, T.A., Metra, M., Adamo, M., Gardner, R.S., Baumbach, A., Böhm, M., et al. (2021) 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. European Heart Journal, 42, 3599-3726. https://doi.org/10.1093/eurheartj/ehab368
[6]  Li, X., Hassoun, H.T., Santora, R. and Rabb, H. (2009) Organ Crosstalk: The Role of the Kidney. Current Opinion in Critical Care, 15, 481-487. https://doi.org/10.1097/mcc.0b013e328332f69e
[7]  Fink, M.P. and Delude, R.L. (2005) Epithelial Barrier Dysfunction: A Unifying Theme to Explain the Pathogenesis of Multiple Organ Dysfunction at the Cellular Level. Critical Care Clinics, 21, 177-196. https://doi.org/10.1016/j.ccc.2005.01.005
[8]  Rangel-Frausto, M.S., Pittet, D., Costigan, M., Hwang, T., Davis, C.S. and Wenzel, R.P. (1995) The Natural History of the Systemic Inflammatory Response Syndrome (SIRS). JAMA, 273, 117-123. https://doi.org/10.1001/jama.1995.03520260039030
[9]  Ricci, Z. and Ronco, C. (2009) Pathogenesis of Acute Kidney Injury during Sepsis. Current Drug Targets, 10, 1179-1183. https://doi.org/10.2174/138945009789753192
[10]  Badr, K.F., Kelley, V.E., Rennke, H.G. and Brenner, B.M. (1986) Roles for Thromboxane A2 and Leukotrienes in Endotoxin-Induced Acute Renal Failure. Kidney International, 30, 474-480. https://doi.org/10.1038/ki.1986.210
[11]  Ravikant, T. and Lucas, C.E. (1977) Renal Blood Flow Distribution in Septic Hyperdynamic Pigs. Journal of Surgical Research, 22, 294-298. https://doi.org/10.1016/0022-4804(77)90146-9
[12]  Langenberg, C., Wan, L., Egi, M., May, C.N. and Bellomo, R. (2006) Renal Blood Flow in Experimental Septic Acute Renal Failure. Kidney International, 69, 1996- 2002. https://doi.org/10.1038/sj.ki.5000440
[13]  Marshall, J.C., Vincent, J., Fink, M.P., Cook, D.J., Rubenfeld, G., Foster, D., et al. (2003) Measures, Markers, and Mediators: Toward a Staging System for Clinical Sepsis. A Report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Critical Care Medicine, 31, 1560-1567. https://doi.org/10.1097/01.ccm.0000065186.67848.3a
[14]  Cunningham, P.N., Dyanov, H.M., Park, P., Wang, J., Newell, K.A. and Quigg, R.J. (2002) Acute Renal Failure in Endotoxemia Is Caused by TNF Acting Directly on TNF Receptor-1 in Kidney. The Journal of Immunology, 168, 5817-5823. https://doi.org/10.4049/jimmunol.168.11.5817
[15]  Calvin, J.E., Driedger, A.A. and Sibbald, W.J. (1981) An Assessment of Myocardial Function in Human Sepsis Utilizing ECG Gated Cardiac Scintigraphy. Chest, 80, 579-586. https://doi.org/10.1378/chest.80.5.579
[16]  Merx, M.W. and Weber, C. (2007) Sepsis and the Heart. Circulation, 116, 793-802. https://doi.org/10.1161/circulationaha.106.678359
[17]  McDonough, K.H., Smith, T., Patel, K. and Quinn, M. (1998) Myocardial Dysfunction in the Septic Rat Heart: Role of Nitric Oxide. Shock, 10, 371-376. https://doi.org/10.1097/00024382-199811000-00011
[18]  Cunnion, R.E., Schaer, G.L., Parker, M.M., Natan-son, C. and Parrillo, J.E. (1986) The Coronary Circulation in Human Septic Shock. Circulation, 73, 637-644. https://doi.org/10.1161/01.cir.73.4.637
[19]  Hinshaw, L.B. (1996) Sepsis/Septic Shock: Participation of the Microcircula-tion: An Abbreviated Review. Critical Care Medicine, 24, 1072-1078. https://doi.org/10.1097/00003246-199606000-00031
[20]  Horton, J.W., Maass, D., White, J. and Sanders, B. (2000) Nitric Oxide Modulation of TNF-α-Induced Cardiac Contractile Dysfunction Is Concentration Dependent. American Journal of Physiology-Heart and Circulatory Physiology, 278, H1955- H1965. https://doi.org/10.1152/ajpheart.2000.278.6.h1955
[21]  Ympa, Y.P., Sakr, Y., Reinhart, K. and Vincent, J. (2005) Has Mortality from Acute Renal Failure Decreased? A Systematic Review of the Literature. The American Journal of Medicine, 118, 827-832. https://doi.org/10.1016/j.amjmed.2005.01.069
[22]  Levy, E.M. (1996) The Effect of Acute Renal Failure on Mortality: A Cohort Analysis. JAMA, 275, 1489-1494. https://doi.org/10.1001/jama.1996.03530430033035

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413